Clinical trial · Interventional
A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis
NCT00430664CI-TRIAL-00000593unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pleurodesis is a technique used to fuse the two layers of the lining over the lung. This is done to get rid of collections of fluid or air in this space. A common reason would be cancer of the underlying lung or elsewhere causing fluid to collect in the pleural space. In this situation it is a palliative procedure to free the patient from symptoms like breathlessness.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Pleural Effusions | — | UNRESOLVED | — |
| Primary Spontaneous Pneumothorax | — | UNRESOLVED | — |
| Recurrent Pleural Effusions | — | UNRESOLVED | — |
| Secondary Spontaneous Pneumothorax | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pleurodesis with either talc or iodopovidone | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Success
- measure
- Failure
Secondary outcomes (4)
- measure
- Death
- measure
- Pain by VAS
- measure
- Time to Pleurodesis
- measure
- Others
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * Age over 12 years * Symptomatic recurrent pleural effusion * Pneumothorax needing pleurodesis Exclusion Criteria: * Life expectancy \<1 month * Unwilling to give consent * Empyema * ICTD drain output \>150 ml/d * Presence of an airleak
References
Publications (0)
Data not yet available
No reference posted for this study.